When will Compass Pathways submit a NDA for COMP360 psilocybin?
14.0 pts (24h)Health & MedicineOne-OffScienceBusiness & Corporate21j
KalshiVérifier la disponibilitéKYC requis2% de fraisDonnées de résolution vérifiéesAssez bien calibréProbabilité implicite actuelle
before April 2027 83%En tête parmi 6 options
Qualité du marché
42 / 100
Faible qualitéVolume 24h
997,3 €
Liquidité
8,7 k €
Liquidité moyenneÉcart
20.0 pt
Spread largeDonnées du marché
Mis à jour il y a 3 minutes
24 mars 26, 14:00 UTC1 oct. 26, 14:00 UTC
Tendances
Marchés Associés
Questions liées pour le contexte, et non une comparaison de contrats équivalents.
When will the FDA approve Compass Pathways' COMP360 Psilocybin?
Kalshi[ACX 2026] Will the FDA approve a psilocybin treatment during 2026?
Manifold MarketsWill psilocybin remain Schedule I through the end of 2027?
Manifold MarketsWill the FDA approve a psilocybin treatment during 2026?
FutuurWhich fast food chain in the USA will offer a lab-grown / cultivated meat product first?
Manifold MarketsWill WHO declare Hantavirus a Public Health Emergency of International Concern this Year?
KalshiRègles
If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Sep 1, 2026, then the market resolves to Yes.
- If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Oct 1, 2026, then the market resolves to Yes.
- If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Nov 1, 2026, then the market resolves to Yes.
- If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Dec 1, 2026, then the market resolves to Yes.
- If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Jan 1, 2027, then the market resolves to Yes.
- If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Apr 1, 2027, then the market resolves to Yes.
Marchés ouverts
Health & Medicine
POLYMARKETHantavirus pandemic in 2026?
- No-0.2pt97%
- Yes+0.2pt3%
- Volume total
- 15,6 M €
- Volume 24h
- 30,4 k €
POLYMARKETEbola pandemic in 2026?
- No-0.1pt97%
- Yes+0.1pt3%
- Volume total
- 652,8 k €
- Volume 24h
- 3,5 k €
KALSHIWill WHO declare Hantavirus a Public Health Emergency of International Concern this Year?
- No97%
- Yes-0.7pt3%
- Volume total
- 1,6 M €
- Volume 24h
- 2,9 k €
KALSHIMeasles cases in 2026?
- Above 300099%
- Above 4000+1.0pt97%
- Above 600059%
+2 résultats de plus
- Volume total
- 865,3 k €
- Volume 24h
- 2,7 k €
POLYMARKETNew pandemic in 2026?
- No+1.0pt94.1%
- Yes-1.0pt5.9%
- Volume total
- 915,3 k €
- Volume 24h
- 1,4 k €
POLYMARKETFDA approves skin cancer vaccine by which date?
- December 31,+1.0pt65%
- September41%
- June28%
- Volume total
- 84 k €
- When will the FDA approve Intellia Therapeutics' lonvo-z?
- Will 3 mg THC beverages be federally legal to sell?
- Cyclosporiasis cases reported in the US in 2026?
- FDA decision: Bepirovirsen by GlaxoSmithKline (in 2026)
- What will the average number of measles cases be during Trump's term?
- Will the FDA approve CagriSema?
- FDA decision: Saroglitazar by Zydus Therapeutics (in 2026)
- Measles cases in U.S. in 2026?
- FDA decision: Ifinatamab Deruxtecan by Daiichi Sankyo (in 2026)
- FDA decision: Anitocabtagene Autoleucel (anito-cel) by Gilead Sciences (in 2026)
- Heidi Overton confirmed as FDA Commissioner by which date?
Questions fréquentes
- Quelles sont les probabilités actuelles pour When will Compass Pathways submit a NDA for COMP360 psilocybin? ?
- Kalshi cote before April 2027 à 83% au 9 septembre 2026.
- Quand When will Compass Pathways submit a NDA for COMP360 psilocybin? sera-t-il résolu ?
- When will Compass Pathways submit a NDA for COMP360 psilocybin? doit être résolu le 1 octobre 2026.
- Comment When will Compass Pathways submit a NDA for COMP360 psilocybin? est-il réglé ?
- Kalshi règle ce marché comme suit : If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Sep 1, 2026, then the market resolves to Yes.